Concepedia

B Osterwalder

BO

Statistics

Publications

30

Citations

6.5K

H-Index

23

Active since

1981

Affiliations

Roche (Switzerland)(Current)

Kantonsspital Baselland

IQVIA (France)

La Roche College

University Hospital Heidelberg

B Osterwalder is an author at Roche (Switzerland) specializing in medicine, pharmacology, and oncology.

ORCID

Publications per year

1981–2009

30

Publications

30

Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

Paulo M. Hoff, Rafat Ansari, Gerald Batist et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

, , +14

Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study

Eric Van Cutsem, Chris Twelves, Jim Cassidy et al. · Journal of Clinical Oncology · 2001 · 1K citations

, , +14

Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer

Joanne L. Blum, Stephen E. Jones, Aman U. Buzdar et al. · Journal of Clinical Oncology · 1999 · 791 citations

, , +16

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorin

Jim Cassidy, Chris Twelves, Eric Van Cutsem et al. · Annals of Oncology · 2002 · 524 citations

, , +16

Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients

Joanne L. Blum, V�ronique Dieras, Patricia Mucci Lo Russo et al. · Cancer · 2001 · 402 citations · Full text

, , +17

1–5 of 30